AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.520
+0.070 (2.03%)
At close: Mar 9, 2026, 4:00 PM EDT
3.560
+0.040 (1.14%)
After-hours: Mar 9, 2026, 7:54 PM EDT

AbCellera Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Cash & Equivalents
128.51156.33133.32386.54476.14
Upgrade
Short-Term Investments
405.31469.29627.27499.95246.84
Upgrade
Cash & Short-Term Investments
533.83625.61760.59886.49722.98
Upgrade
Cash Growth
-14.67%-17.75%-14.20%22.62%21.69%
Upgrade
Accounts Receivable
58.2933.6230.5938.59160.58
Upgrade
Other Receivables
55.726.5333.7964.8214.28
Upgrade
Receivables
153.492.1364.38103.41174.86
Upgrade
Inventory
6.34--1.531.67
Upgrade
Prepaid Expenses
9.678.6322.029.065.29
Upgrade
Restricted Cash
2525252525
Upgrade
Total Current Assets
728.23751.37871.991,025929.8
Upgrade
Property, Plant & Equipment
428340.43287.7217.26111.62
Upgrade
Long-Term Investments
94.88114.865.9434.4232.31
Upgrade
Goodwill
47.8147.8147.8147.8147.81
Upgrade
Other Intangible Assets
38.3842.11120.43131.5148.39
Upgrade
Other Long-Term Assets
19.6534.4480.3440.8330.64
Upgrade
Total Assets
1,3571,3611,4881,5411,319
Upgrade
Accounts Payable
25.2334.3528.614.8314.92
Upgrade
Accrued Expenses
10.768.387.7125.826.54
Upgrade
Current Portion of Leases
5.824.626.165.583.65
Upgrade
Current Income Taxes Payable
----35.68
Upgrade
Current Unearned Revenue
22.5121.1826.0727.912.01
Upgrade
Other Current Liabilities
-8.0950.4844.2127.87
Upgrade
Total Current Liabilities
64.3176.61119.01118.32120.68
Upgrade
Long-Term Leases
137.460.7471.2276.6836.41
Upgrade
Long-Term Unearned Revenue
174.45149.89104.1160.3260.76
Upgrade
Long-Term Deferred Tax Liabilities
9.1210.0530.6133.1837.37
Upgrade
Other Long-Term Liabilities
4.777.1710.8219.1437.62
Upgrade
Total Liabilities
390.05304.47335.78307.63292.84
Upgrade
Common Stock
802.34777.17753.2734.37722.43
Upgrade
Additional Paid-In Capital
198.28166.36121.0574.1235.36
Upgrade
Retained Earnings
-29.48116.93279.79426.19267.67
Upgrade
Comprehensive Income & Other
-4.23-4.38-1.72-1.390.28
Upgrade
Total Common Equity
966.91,0561,1521,2331,026
Upgrade
Shareholders' Equity
966.91,0561,1521,2331,026
Upgrade
Total Liabilities & Equity
1,3571,3611,4881,5411,319
Upgrade
Total Debt
143.2265.3677.3882.2640.07
Upgrade
Net Cash (Debt)
390.61560.25683.21804.23682.91
Upgrade
Net Cash Growth
-30.28%-18.00%-15.05%17.76%15.80%
Upgrade
Net Cash Per Share
1.311.902.362.552.15
Upgrade
Filing Date Shares Outstanding
303.16297.99292.78287.69283.92
Upgrade
Total Common Shares Outstanding
300.6295.76290.82286.85283.26
Upgrade
Working Capital
663.93674.76752.97907.17809.12
Upgrade
Book Value Per Share
3.223.573.964.303.62
Upgrade
Tangible Book Value
880.72966.17984.091,054829.54
Upgrade
Tangible Book Value Per Share
2.933.273.383.672.93
Upgrade
Land
53.4153.4153.4153.4133.04
Upgrade
Buildings
193.16175.8143.9511.361.21
Upgrade
Machinery
102.9484.2973.8749.5626.65
Upgrade
Leasehold Improvements
--73.9440.5722.75
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.